Journal of the American Society of Hypertension
Volume 3, Issue 4 , Pages 238-244 , July 2009

A HMGCR polymorphism is associated with relations between blood pressure and urinary sodium and potassium ratio in the Epic-Norfolk Study

  • Renata N. Freitas, MBiochem, PhD

      Affiliations

    • Departmento de Nutrição Clinica e Social, School of Nutrition and Núcleo de Pesquisas em Ciências Biológicas, Federal University of Ouro Preto, Ouro Preto, Brazil
    • Medical Research Council Center for Nutritional Epidemiology in Cancer Prevention and Survival, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom
    • Corresponding Author InformationCorresponding author: Renata N. Freitas, MBiochem, PhD, DENCS/ENUT/UFOP, Campus Universitario, Morro de Cruzeiro, Ouro Preto, MG, 35400000, Brazil. Tel: +55 31 35591838; fax: +55 31 55591828.
    • ,
  • Kay-Tee Khaw, MBBChir

      Affiliations

    • Medical Research Council Center for Nutritional Epidemiology in Cancer Prevention and Survival, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom
    • EPIC Norfolk, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom
    • ,
  • Kelvin Wu, PhD

      Affiliations

    • Medical Research Council Dunn Human Nutrition Unit, University of Cambridge, Cambridge, United Kingdom
    • ,
  • Richard Bowman, BSc

      Affiliations

    • Medical Research Council Dunn Human Nutrition Unit, University of Cambridge, Cambridge, United Kingdom
    • ,
  • Hannah Jeffery, MBiochem

      Affiliations

    • Medical Research Council Dunn Human Nutrition Unit, University of Cambridge, Cambridge, United Kingdom
    • ,
  • Robert Luben, BSc

      Affiliations

    • EPIC Norfolk, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom
    • ,
  • Nick J. Wareham, MBBS, PhD

      Affiliations

    • EPIC Norfolk, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom
    • Medical Research Council Epidemiology Unit, University of Cambridge, Cambridge, United Kingdom
    • ,
  • Sheila A. Bingham, PhD

      Affiliations

    • Medical Research Council Center for Nutritional Epidemiology in Cancer Prevention and Survival, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom
    • EPIC Norfolk, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom
    • Medical Research Council Dunn Human Nutrition Unit, University of Cambridge, Cambridge, United Kingdom

Received 10 March 2009 ,Accepted 28 May 2009.

References 

  1. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet. 2005;365:217–223
  2. Wierzbicki AS. Lipid lowering: another method of reducing blood pressure?. J Hum Hypertens. 2002;16:753–760
  3. Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report. Circulation. 2002;106:3143–3342
  4. Leitersdorf E, Hwang M, Luskey KL. ScrFI polymorphism in the 2nd intron of the HMGCR gene [abstract]. Nucleic Acids Res. 1990;18:5584
  5. Leitersdorf E, Luskey KL. HgiAI polymorphism near the HMGCR promoter [abstract]. Nucleic Acids Res. 1990;18:5584
  6. Zuliani G, Hobbs HH. A high frequency of length polymorphism in repeated sequences adjacent to Alu sequences. Am J Hum Genet. 2008;46:963–969
  7. Chasman DI, Posada D, Subrahmanyan L, Cook NR, Stanton VP, Ridker PM. Pharmacogenetic study of statin therapy and cholesterol reduction. JAMA. 2004;291:2821–2827
  8. Strehlow K, Wassmann S, Böhm M, Nickenig G. Angiotensin AT1 receptor over-expression in hypercholesterolaemia. Ann Med. 2000;32:386–389
  9. Park H-J, Kong D, Iruela-Arispe L, Begley U, Tang D, Galper J. 3-Hydroxy-3-Methylglutaryl coenzyme A reductase inhibitors interfere with angiogenesis by inhibiting the geranylgeranylation of RhoA. Circulation Res. 2002;91:143–150
  10. Ichiki T, Takeda K, Tokunou T, Iino N, Egashira K, Shimokawa H, et al. Downregulation of angiotensin II type 1 receptor by hydrophobic 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol. 2001;21:1896–1901
  11. Hubacek JA, Pistulková H, Valenta Z, Poledne R. (TTA)n repeat polymorphism in the HMG-CoA reductase gene and cholesterolaemia. VASA. 1999;28:169–171
  12. Plat J, Mensink RP. Relationship of genetic variation in genes encoding apolipoprotein A-IV, scavenger receptor BI, HMG-CoA reductase, CETP, and apolipoprotein E with cholesterol metabolism and the response to plant stanol ester consumption. Eur J Clin Invest. 2002;32:242–250
  13. Tong Y, Zhang S, Li H, Su Z, Kong X, Liu H, et al. 8302A/C and (TTA)n polymorphisms in the HMG-CoA reductase gene may be associated with some plasma lipid metabolic phenotypes in patients with coronary heart disease. Lipids. 2004;39:239–241
  14. Rasmussen MS, Simonsen JA, Sandgaard NCF, Hoilund-Carlsen PF, Bie P. Mechanisms of acute natriuresis in normal humans on low sodium diet. J Physiol. 2003;546:591–603
  15. Bie P, Sandgaard NCF. Determinants of the natriuresis after acute, slow sodium loading in conscious dogs. Am J Physiol Regul Integr Comp Physiol. 2000;278:R1–R10
  16. Sandgaard NCF, Andersen JL, Bie P. Hormonal regulation of renal sodium and water excretion during normotensive sodium loading in conscious dogs. Am J Physiol Regul Integr Comp Physiol. 2000;278:R11–R18
  17. Graudal NA, Galloe AM, Garred P. Effects of sodium restriction on blood pressure, renin, aldosterone, catecholamines, cholesterols, and triglycerides. JAMA. 1998;279:1383–1391
  18. Hunt SC, Geleijnse JM, Wu LL, Witteman JC, Williams RR, Grobbee DE. Enhanced blood pressure response to mild sodium reduction in subjects with the 235T variant of the angiotensinogen gene. Am J Hypertens. 1999;12:460–466
  19. Johnson AG, Nguyen TV, Davis D. Blood pressure is linked to salt intake and modulated by the angiotensinogen gene in normotensive and hypertensive elderly subjects. J Hypertens. 2001;19:1053–1060
  20. Norat T, Bowman R, Luben R, Welch A, Khaw KT, Wareham N, et al. Blood pressure and interactions between the angiotensin polymorphism AGT M235T and sodium intake: a cross-sectional population study. Am J Clin Nutr. 2008;88:392–397
  21. Khaw KT, Bingham S, Welch A, Luben R, O'Brien E, Wareham N, et al. Blood pressure and urinary sodium in men and women: the Norfolk Cohort of the European Prospective Investigation into Cancer (EPIC—Norfolk). Am J Clin Nutr. 2004;80:1397–1403
  22. Wareham NJ, Jakes RW, Rennie KL, Schuit J, Mitchell J, Hennings S, et al. Validity and repeatability of a simple index derived from the short physical activity questionnaire used in the European Prospective Investigation into Cancer and Nutrition (EPIC) Study. Public Health Nutr. 2003;6:407–413
  23. Ahmadian A, Gharizadeh B, Gustafsson AC, Sterky F, Nyren P, Uhlen M, et al. Single-nucleotide polymorphism analysis by pyrosequencing. Anal Biochem. 2000;280:103–110
  24. Nyren P, Karamohamed S, Ronaghi M. Detection of single-base changes using a bioluminometric primer extension assay. Anal Biochem. 1997;244:367–373
  25. Ronaghi M, Karamohamed S, Pettersson B, Uhlen M, Nyren P. Real-time DNA sequencing using detection of pyrophosphate release. Anal Biochem. 1996;242:84–89
  26. Amarenco P, Lavallee P, Touboul PJ. Stroke prevention, blood cholesterol, and statins. Lancet Neurol. 2004;3:271–278
  27. Bellosta S, Ferri N, Bernini F, Paoletti R, Corsini A. Non-lipid-related effects of statins. Ann Med. 2000;32:164–176
  28. Glorioso N, Troffa C, Filigheddu F, Dettori F, Soro A, Parpaglia PP, et al. Effect of the HMG-CoA Reductase inhibitors on blood pressure in patients with essential hypertension and primary hypercholesterolemia. Hypertension. 1999;34:1281–1286
  29. Golomb BA, Dimsdale JE, White HL, Ritchie JB, Criqui MH. Reduction in blood pressure with statins: results from the UCSD Statin Study, a randomized trial. Arch Intern Med. 2008;168:721–727
  30. Paciaroni M, Hennerici M, Agnelli G, Bogousslavsky J. Statins and stroke prevention. Cerebrovasc Dis. 2007;24:170–182
  31. Calhoun DA, Oparil S. The sexual dimorphism of high blood pressure. Cardiol Rev. 1998;6:356–363
  32. Huxley VH. Sex and the cardiovascular system: the intriguing tale of how women and men regulate cardiovascular function differently. Adv Physiol Educ. 2007;31:17–22
  33. Mendelsohn ME, Karas RH. Molecular and cellular basis of cardiovascular gender differences. Science. 2005;308:1583–1587
  34. Bingham SA, Gill C, Welch A, Cassidy A, Runswick SA, Oakes S, et al. Validation of dietary assessment methods in the United Kingdom arm of EPIC using weighed records, and 24-hour urinary nitrogen and potassium and serum vitamin C and carotenoids as biomarkers. Int J Epidemiol. 1997;26:S137–S151
  35. Bellosta S, Paoletti R. Statin therapy and prevention of stroke. Curr Atheroscler Rep. 2000;2:181–182
  36. Cooke GE. Pharmacogenetics of multigenic disease: Heart disease as an example. Vascular Pharmacology. 2006;44:66–74
  37. Polisecki E, Muallem H, Maeda N, Peter I, Robertson M, McMahon AD, et al. Genetic variation at the LDL receptor and HMG-CoA reductase gene loci, lipid levels, statin response, and cardiovascular disease incidence in PROSPER. Atherosclerosis. 2008;200:109–114
  38. Schmitz G, Drobnik W. Pharmacogenomics and pharmacogenetics of cholesterol-lowering therapy. Clin Chem Lab Med. 2003;41:581–589
  39. Singer JB, Holdaas H, Jardine AG, Fellstrom B, Os I, Bermann G, et al. Genetic analysis of fluvastatin response and dyslipidemia in renal transplant recipients. J Lipid Res. 2007;48:2072–2078
  40. Berko BA. Gender-related differences in cardiomyopathy. Cardiovasc Clin. 1989;19:285–300
  41. Hartel U. Gender issues in the epidemiology of cardiovascular diseases. Ther Umsch. 2007;64:297–304
  42. McBride SM, Flynn FW, Ren J. Cardiovascular alteration and treatment of hypertension: do men and women differ?. Endocrine. 2005;28:199–207
  43. Regitz-Zagrosek V, Lehmkuhl E, Mahmoodzadeh S. Gender aspects of the role of the metabolic syndrome as a risk factor for cardiovascular disease. Gend Med. 2007;4:S162–S177
  44. Hurwitz S, Fisher ND, Ferri C, Hopkins PN, Williams GH, Hollenberg NK. Controlled analysis of blood pressure sensitivity to sodium intake: interactions with hypertension type. J Hypertens. 2003;21:951–959
  45. Hollenberg NK, Moore T, Shoback D, Redgrave J, Rabinowe S, Williams GH. Abnormal renal sodium handling in essential hypertension. Relation to failure of renal and adrenal modulation of responses to angiotensin II. Am J Med. 1986;81:412–418
  46. Luft FC, Miller JZ, Cohen SJ, Fineberg NS, Weinberger MH. Heritable aspects of salt sensitivity. Am J Cardiol. 1988;61:1H–6
  47. Wassmann S, Laufs U, Bäumer AT, Müller K, Konkol C, Sauer H, et al. Mediated free radical production in vascular smooth muscle cells: involvement of angiotensin AT1 receptor expression and Rac GTPase. Mol Pharmacol. 2001;59:646–654
  48. Rupérez M, Rodrigues-Díez R, Blanco-Colio LM, Sánchez-López E, Rodríguez-Vita J, Esteban V, et al. HMG-CoA reductase inhibitors decrease angiotensin II-induced vascular fibrosis: role of RhoA/ROCK and MAPK pathways. Hypertension. 2007;50:377–383

 This study was supported by Programme Grants from the Medical Research Council, London, United Kingdom; Cancer Research, London, United Kingdom; and Conselho Nacional de Desenvolvimento Científico e Tecnológico – CNPq, Brazil (a fellowship to Dr. Freitas).

 Conflict of interest: none.

PII: S1933-1711(09)00066-7

doi: 10.1016/j.jash.2009.05.001

Journal of the American Society of Hypertension
Volume 3, Issue 4 , Pages 238-244 , July 2009

Article Tools